Pfizer's GLP-1 Drug Xianweiying Wins China Approval for Long-Term Weight Management sheeba farhat8 March 2026 11:30 AM ISTShanghai: China has approved Pfizer's GLP-1 treatment Xianweiying for long-term weight management in overweight or obese adults, the US drugmaker said...
Patients regain weight rapidly after stopping weight loss drugs-but still keep off quarter of weight lost, states study Dr. Kamal Kant Kohli5 March 2026 8:45 PM ISTA year after stopping taking weight loss drugs such as Ozempic and Wegovy, people regain on average 60% of their lost weight-but beyond this, their...
India's Semaglutide Market Set for Generic Boom as Patents Expire, Over 50 Brands Lined Up for Launch, See Full List Farhat Nasim4 March 2026 10:15 PM ISTNew Delhi: The expiry of semaglutide's key patent in India in March 2026 is ushering in a tsunami of generic versions of the blockbuster diabetes and...
Novo Nordisk to Invest USD 506 Million to Expand Oral GLP-1 Drug Manufacturing in Ireland sheeba farhat3 March 2026 8:46 PM ISTNew Delhi: Novo Nordisk said on Monday it will invest 432 million euros (USD 506.43 million) to expand its manufacturing facility in Athlone,...
7 Pharma Firms Eye Generic Semaglutide, Prices May Fall 50% Post Patent Expiry: Report Parthika Patel27 Feb 2026 7:40 PM ISTNew Delhi: Prices of widely used weight-loss drugs such as Wegovy and Ozempic are expected to drop significantly in India after the semaglutide patent...
USFDA Flags Novo Nordisk's Wegovy Advertisement as False, Seeks Immediate Action sheeba farhat11 Feb 2026 8:19 PM ISTUSFDA said the television spot misleadingly suggests that Wegovy in its pill form offers an advancement or improvement over other weight-loss drugs...
Novo Nordisk Loses USD 50 Billion as Obesity Drug Price War Triggers Profit, Sales Warning sheeba farhat6 Feb 2026 11:15 AM ISTNew Delhi: Novo Nordisk's shares tumbled on Wednesday, knocking nearly USD 50 billion in value from the Danish obesity drug giant, as it warned that...
Novo Nordisk's Wegovy Gets UK Nod for Higher 7.2 mg Weekly Dose in Obesity Treatment sheeba farhat17 Jan 2026 4:06 PM ISTThe authorisation for the drug, chemically known as semaglutide, covers only patients with a body mass index of 30 or higher using the drug for weight...
No Link to Suicidal Thoughts: USFDA Seeks Label Change for Popular Weight-Loss Drugs Wegovy, Zepbound sheeba farhat14 Jan 2026 6:57 PM ISTThe warnings, part of their original approval, were based on reports of such events observed with a variety of older medicines used or studied for...
Medical Bulletin 10/January/2026 Anshika Mishra10 Jan 2026 3:00 PM ISTHere are the top medical news for today:Review suggests most GLP-1 users regain weight within two years after stopping Weight loss drugs work wonders...
Review suggests most GLP-1 users regain weight within two years after stopping Anshika Mishra10 Jan 2026 8:00 AM ISTWeight loss drugs work wonders for shedding pounds, but stopping them can bring the weight back faster than ever. A new University of Oxford review...
Natco Pharma Challenges Novo Nordisk's Wegovy Patent, Reaches Delhi High Court Susmita Roy7 Jan 2026 11:19 PM ISTNew Delhi: Hyderabad-based Natco Pharma has approached the Delhi High Court with a petition seeking revocation of a patent held by Novo Nordisk, the...
